|
Re: Food For Thought
|
4
|
Resverlogix Corp.
|
Oct 17, 2019 03:07PM
|
|
Re: 2 year extension
|
4
|
Resverlogix Corp.
|
May 14, 2024 01:49PM
|
|
Re: Notice anything different about #11
|
4
|
Zenith Epigenetics
|
Oct 26, 2023 10:10PM
|
|
Re: For what it’s worth
|
4
|
Zenith Epigenetics
|
Jul 20, 2023 08:35AM
|
|
Re: I am looking forward to Dec 4th...
|
4
|
Resverlogix Corp.
|
Nov 01, 2019 12:33PM
|
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
4
|
Zenith Epigenetics
|
May 13, 2022 09:54PM
|
|
Re: 2:35 a.m. (=8:31 a.m. ET - utter silence on the webcast.
|
4
|
Resverlogix Corp.
|
Sep 30, 2019 08:56AM
|
|
Re: ...is anybody out there at the AGM...?
|
4
|
Resverlogix Corp.
|
Oct 01, 2015 11:40AM
|
|
Biogen
|
5
|
Resverlogix Corp.
|
Dec 02, 2019 06:58PM
|
|
Re: Since GAC....
|
5
|
Resverlogix Corp.
|
Feb 29, 2020 05:42PM
|
|
Re: Trial delay
|
5
|
Resverlogix Corp.
|
May 04, 2021 08:55PM
|
|
Re: A message from Kelsee.....
|
5
|
Resverlogix Corp.
|
Oct 29, 2021 02:45PM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
5
|
Resverlogix Corp.
|
Dec 22, 2020 10:08AM
|
|
Opportunity continues to knock
|
5
|
Resverlogix Corp.
|
Aug 13, 2024 07:45AM
|
|
Pfizer
|
5
|
Zenith Epigenetics
|
Mar 11, 2024 07:39AM
|
|
While we fiddle
|
5
|
Resverlogix Corp.
|
Jul 20, 2023 08:10AM
|
|
Re: Too good "to be allowed" to be true?
|
5
|
Resverlogix Corp.
|
Jan 01, 2018 11:16AM
|
|
Re: Shake it Up!
|
5
|
Resverlogix Corp.
|
Dec 24, 2020 01:12PM
|
|
Re: Zenith Epigenetics Corp. Commences Operations
|
5
|
Zenith Epigenetics
|
Dec 08, 2015 08:18PM
|
|
Re: AGM Voting
|
5
|
Zenith Epigenetics
|
Oct 16, 2022 07:13PM
|
